Vimarsana
Biggest News Aggregation in the World

Page 2 - Critically Ill News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Critically Ill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Critically Ill Today - Breaking & Trending Today

Critically ill British girl taken off life support dies - Vimarsana News

Critically ill British girl taken off life support dies

LONDON/ROME (Reuters) -Indi Gregory, a critically ill eight-month-old baby girl from Britain who was taken off life support over the weekend following a legal battle, has died overnight, her family said on Monday. The baby died at 0145 GMT, Dean Gregory, her father, said in a statement issued by charity Christian Concern.

Source: yahoo.com
Critically ill 8-month-old removed from life support after parents battle in court in UK - Vimarsana News

Critically ill 8-month-old removed from life support after parents battle in court in UK

UK judges insisted it was in Indi Gregory's best interest to peacefully die in hospice care despite calls from her parents to send her to Italy.

Source: yahoo.com
Indi Gregory: Latest appeal from family of critically ill baby refused - Vimarsana News

Indi Gregory: Latest appeal from family of critically ill baby refused

Indi Gregory's parents wanted to overturn a decision to refuse a transfer to a hospital in Italy.

Source: yahoo.com
InflaRx N : 11-2023-InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update -November 01, 2023 at 09:13 am EDT - Vimarsana News

InflaRx N : 11-2023-InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update -November 01, 2023 at 09:13 am EDT

Jena, Germany, November 1, 2023 - InflaRx N.V. , a biotechnology company pioneering anti-inflammatory therapeutics targeting the complement system, announced today financial results...

InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

InflaRx Reports Third Quarter 2023 Financial Results and Provides Business Update

Single ascending dose (SAD) Phase I data confirm best-in-class potential of orally available C5aR inhibitor INF904; multiple ascending dose (MAD) ...